(Q47971036)

7 February 2018

title

Anxiolytic effects of vestipitant in a sub-group of healthy volunteers known to be sensitive to CO2 challenge. (English)

1 reference

7 February 2018

Massimo Bani

4

0 references

author name string

Stefano Zanone Poma

1

1 reference

7 February 2018

Emilio Merlo-Pich

2

1 reference

7 February 2018

Paolo Bettica

3

1 reference

7 February 2018

Paolo Fina

5

1 reference

7 February 2018

Luigi Ziviani

6

1 reference

7 February 2018

Stefano Milleri

7

1 reference

7 February 2018

language of work or name

English

0 references

publication date

9 October 2013

1 reference

7 February 2018

Journal of Psychopharmacology

published in

1 reference

7 February 2018

volume

28

1 reference

7 February 2018

page(s)

491-497

1 reference

7 February 2018

issue

5

1 reference

7 February 2018

Inhalation of 35% CO(2) results in activation of the HPA axis in healthy volunteers

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Preliminary evidence of anxiolytic effects of the CRF(1) receptor antagonist R317573 in the 7.5% CO(2) proof-of-concept experimental model of human anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Validating the inhalation of 7.5% CO(2) in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Approximate entropy of respiratory patterns in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Smoking and respiratory irregularity in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Anxiety responses to CO2 inhalation in subjects at high-risk for panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Tachykinin receptors as therapeutic targets in stress-related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Evoking analogue subtypes of panic attacks in a nonclinical population using carbon dioxide-enriched air.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

The effect of neurokinin1 receptor blockade on territorial aggression and in a model of violent aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Assessment of antidepressant and anxiolytic properties of NK1 antagonists and substance P in Wistar Kyoto rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Do substance P and the NK1 receptor have a role in depression and anxiety?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Genetic moderation of CO2-induced fear by 5-HTTLPR genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Effects of 7.5% CO2 challenge in generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Effects of alprazolam and clonidine on carbon dioxide-induced increases in anxiety ratings in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113507641

21 January 2018

Identifiers

DOI

10.1177/0269881113507641

1 reference

7 February 2018

release_lratjctmkjbojie4zbisfgbj4m

Fatcat ID

0 references

PubMed ID

24108409

1 reference

7 February 2018